Inventor
NG PUI YEE
US79 patents
⚠️ This page may combine multiple inventors who share the name “NG PUI YEE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
29 patentsUS10112915B2Oct 30, 2018
3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC41 citations99
US10494353B2Dec 3, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10494354B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10472337B2Nov 12, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10450283B2Oct 22, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC14 citations98
US10450284B2Oct 22, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC14 citations98
US10442776B2Oct 15, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10428031B2Oct 1, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10421732B2Sep 24, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC16 citations98
US10421731B2Sep 24, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10414738B2Sep 17, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC16 citations98
US10377726B2Aug 13, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC22 citations98
US10239845B2Mar 26, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC25 citations98
US10214501B2Feb 26, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC20 citations98
US10214500B2Feb 26, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC20 citations98
US9637453B2May 2, 2017
3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
FORMA THERAPEUTICS INC51 citations98
US9630922B2Apr 25, 2017
3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors
FORMA THERAPEUTICS INC49 citations98
US10407418B2Sep 10, 2019
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC16 citations94
US10183934B2Jan 22, 2019
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC27 citations94
US10513501B2Dec 24, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC11 citations93
US10494351B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10494352B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10479772B2Nov 19, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC6 citations93
US10464909B2Nov 5, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10464910B2Nov 5, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10457652B2Oct 29, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10555935B2Feb 11, 2020
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
FORMA THERAPEUTICS INC11 citations86
US10266487B2Apr 23, 2019
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC4 citations84
US9745253B2Aug 29, 2017
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC10 citations84
VALO HEALTH INC
8 patentsUS11279681B2Mar 22, 2022
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC6 citations94
US11702412B2Jul 18, 2023
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC4 citations86
US12213969B2Feb 4, 2025
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
VALO HEALTH INC2 citations75
US12264137B2Apr 1, 2025
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC0 citations73
US11891365B2Feb 6, 2024
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC1 citations73
US11730721B2Aug 22, 2023
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
VALO HEALTH INC3 citations73
US11345672B2May 31, 2022
Methods using HDAC11 inhibitors
VALO HEALTH INC2 citations73
US11274084B2Mar 15, 2022
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC1 citations73
VALO EARLY DISCOVERY INC
6 patentsUS10829462B2Nov 10, 2020
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC15 citations98
US10829461B2Nov 10, 2020
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC15 citations98
US10822316B2Nov 3, 2020
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC10 citations93
US10988450B2Apr 27, 2021
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC6 citations92
US10874649B2Dec 29, 2020
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
VALO EARLY DISCOVERY INC9 citations84
US10870645B2Dec 22, 2020
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC9 citations84
SIRTRIS PHARMACEUTICALS INC
5 patentsUS7345178B2Mar 18, 2008
Sirtuin modulating compounds
SIRTRIS PHARMACEUTICALS INC158 citations98
US7829556B2Nov 9, 2010
Sirtuin modulating compounds
SIRTRIS PHARMACEUTICALS INC115 citations96
US8044198B2Oct 25, 2011
Sirtuin modulating compounds
SIRTRIS PHARMACEUTICALS INC29 citations92
US7893086B2Feb 22, 2011
Sirtuin modulating compounds
SIRTRIS PHARMACEUTICALS INC34 citations92
US7855289B2Dec 21, 2010
Sirtuin modulating compounds
SIRTRIS PHARMACEUTICALS INC34 citations90
NUNES JOSEPH J
2 patentsShowing the top 50 of 79 patents by PatentIndex Score.